Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TYR | P14679 | 2/20 | 0.37 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.37 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.37 |
| ▸ | CTRC | Q99895 | 1/20 | 0.34 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.32 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.32 |
| ▸ | PDE4A | P27815 | 3/20 | 0.32 |
| ▸ | PDE4B | Q07343 | 3/20 | 0.32 |
| ▸ | PDE4C | Q08493 | 3/20 | 0.32 |
| ▸ | PDE4D | Q08499 | 3/20 | 0.32 |
| ▸ | PDE3B | Q13370 | 2/20 | 0.32 |
| ▸ | PDE3A | Q14432 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.32 |
| ▸ | GAA | P10253 | 1/20 | 0.32 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.32 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.32 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Cyanide SCHEMBL27546696 | 0.94 | TYR (0.34) | TYRSLC6A4SLC6A3CTRCLIPG | |
| SCHEMBL2795698 | 0.94 | LIPG (0.39) | TYRSLC6A4SLC6A3LIPGALDH1A1 | |
| SCHEMBL5170070 | 0.92 | LIPG (0.42) | TYRSLC6A4SLC6A3LIPGALDH1A1 | |
| SCHEMBL20338197 | 0.92 | LIPG (0.42) | TYRSLC6A4SLC6A3LIPGALDH1A1 | |
| SCHEMBL1225175 | 0.92 | LIPG (0.42) | TYRSLC6A4SLC6A3LIPGALDH1A1 | |
| SCHEMBL329220 | 0.92 | LIPG (0.42) | TYRSLC6A4SLC6A3LIPGALDH1A1 | |
| SCHEMBL19304410 | 0.92 | LIPG (0.42) | TYRSLC6A4SLC6A3LIPGALDH1A1 | |
| SCHEMBL5147986 | 0.92 | LIPG (0.42) | TYRSLC6A4SLC6A3LIPGALDH1A1 | |
| SCHEMBL198675 | 0.92 | LIPG (0.42) | TYRSLC6A4SLC6A3LIPGALDH1A1 | |
| SCHEMBL2145395 | 0.92 | LIPG (0.42) | TYRSLC6A4SLC6A3LIPGALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122059923-A | Aldehyde group-guided bi (hetero) aromatic compound and synthesis method and application thereof | 桂林理工大学 | 2026-05-19 | — | — | CN | disclosed |
| CN-103025729-B | Transpirable organic semiconducting materials and the purposes in photoelectric cell thereof | HELIATEK GMBH (DE) | 2016-05-25 | — | — | CN | disclosed |
| US-9127020-B2 | Evaporable organic semiconductive material and use thereof in an optoelectronic component | HELIATEK GMBH (DE) | 2015-09-08 | — | — | US | disclosed |
| US-9018397-B2 | Pyrrolopyrrole derivatives, their manufacture and use | BASF SE (DE) | 2015-04-28 | — | — | US | disclosed |
| US-9018397-B2 | Pyrrolopyrrole derivatives, their manufacture and use | BASF SE (DE) | 2015-04-28 | — | — | US | disclosed |
| EP-2483267-B9 | EVAPORABLE ORGANICALLY SEMICONDUCTIVE MATERIAL AND USE THEREOF IN AN OPTOELECTRONIC COMPONENT | HELIATEK GMBH (DE) | 2014-05-14 | — | — | EP | disclosed |
| EP-2483267-B9 | EVAPORABLE ORGANICALLY SEMICONDUCTIVE MATERIAL AND USE THEREOF IN AN OPTOELECTRONIC COMPONENT | HELIATEK GMBH (DE) | 2014-05-14 | — | — | EP | disclosed |
| EP-2483267-B1 | EVAPORABLE ORGANICALLY SEMICONDUCTIVE MATERIAL AND USE THEREOF IN AN OPTOELECTRONIC COMPONENT | HELIATEK GMBH (DE) | 2013-08-28 | — | — | EP | disclosed |
| EP-2483267-B1 | EVAPORABLE ORGANICALLY SEMICONDUCTIVE MATERIAL AND USE THEREOF IN AN OPTOELECTRONIC COMPONENT | HELIATEK GMBH (DE) | 2013-08-28 | — | — | EP | disclosed |
| US-20130172575-A1 | Pyrrolopyrrole derivatives, their manufacture and use | BASF SE (DE) | 2013-07-04 | — | — | US | disclosed |
| US-20030216388-A1 | Cyclocarbamate derivatives as progesterone receptor modulators | WYETH | 2003-11-20 | — | — | US | disclosed |
| US-6566358-B2 | 1,4-dihydro-benzo(d)oxazin-2-one derivatives useful for treating hormone-dependent neoplastic disease is selected from uterine myometrial fibroids, endometriosis, benign prostatic hypertrophy, carcinomas, and adenocarcinoma | WYETH | 2003-05-20 | — | — | US | disclosed |
| US-20030045511-A1 | Combination regimens using progesterone receptor modulators | WYETH | 2003-03-06 | — | — | US | disclosed |
| US-6509334-B1 | This invention relates to compounds that antagonists of the progesterone receptor, their preparation and utility. Intracellular receptors (IR) form a class of structurally related gene regulators known as \"ligand dependent | AMERICAN HOME PRODUCTS CORPORATION | 2003-01-21 | — | — | US | disclosed |
| US-6444668-B1 | IN COMBINATION WITH A PROGESTIN, AN ESTROGEN, OR BOTH; ANTIPROGESTIN IS A 1,4-DIHYDRO-BENZO(D)(1.3)OXAZIN-2-ONE | WYETH | 2002-09-03 | — | — | US | disclosed |
| US-20020049204-A1 | Cyclocarbamate derivatives as progesterone receptor modulators | WYETH | 2002-04-25 | — | — | US | disclosed |
| EP-1173426-A1 | CYCLOCARBAMATE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS | American Home Products Corporation (US) | 2002-01-23 | — | — | EP | disclosed |
| EP-1173210-A1 | CONTRACEPTIVE COMPOSITIONS CONTAINING ANTIPROGESTINIC AND PROGESTINIC | American Home Products Corporation (US) | 2002-01-23 | — | — | EP | disclosed |
| WO-2000066571-A1 | CYCLOCARBAMATE DERIVATIVES AS PROGESTERONE RECEPTOR MODULATORS | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-11-09 | — | — | WO | disclosed |
| WO-2000066164-A1 | CONTRACEPTIVE COMPOSITIONS CONTAINING ANTIPROGESTINIC AND PROGESTINIC | AMERICAN HOME PRODUCTS CORPORATION (US) | 2000-11-09 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030045511-A1 | Combination regimens using progesterone receptor modulators | GNRHR, PGR, PRLHR | TYR 4657/4885SLC6A4 1570/4885SLC6A3 1697/4885 |
| US-20030216388-A1 | Cyclocarbamate derivatives as progesterone receptor modulators | NR3C2, NR5A1, PGR | TYR 4844/4885SLC6A4 2154/4885SLC6A3 2009/4885 |
| US-20020049204-A1 | Cyclocarbamate derivatives as progesterone receptor modulators | NR3C1, NR5A1, CNR1 | TYR 4788/4885SLC6A4 2071/4885SLC6A3 1271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.